Results 191 to 200 of about 32,355 (207)
Some of the next articles are maybe not open access.

5,6-dihydroxyindole formation from oxidized 6-hydroxydopamine

European Journal of Pharmacology, 1972
Abstract Within 1 hr oxidized 6-hydroxydopamine solutions at 37°C and pH 7.4 produce significant quantities of 5,6-dihydroxyindole. An analog, 6-aminodopamine, also a powerful norepinephrine depletor in mouse brain, provides the same 5,6-hydroxyindoles.
C L, Blank, P T, Kissinger, R N, Adams
openaire   +2 more sources

6-Hydroxydopamine therapy in glaucoma.

Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology, 1977
At the inception of this study, 6-hydroxydopamine (6-HD) was administered to 137 eyes of 100 glaucoma patients by subconjunctival injection (27 applications) and later by iontophoresis (202 applications). Eighty-four patients were receiving maximum medical therapy, and 24 had had previous glaucoma surgery. Seventy-seven had primary open-angle glaucoma.
H, Watanabe, R Z, Levene, M R, Bernstein
openaire   +1 more source

Effect of 6-hydroxydopamine on morphine analgesia

Psychopharmacologia, 1972
The influence of 6-OHDA on morphine analgesia estimated by the hot-plate method was investigated in rats. 6-OHDA injected intraventricularly at a dose of 250 Μg/rat, significantly and specifically depleted catecholamines from the brain. Morphine (7.5 mg/kg) produced a prominent analgesia in untreated and sham-injected rats whilst the reaction times of ...
openaire   +2 more sources

Feeding Behavior after Hypothalamic 6-Hydroxydopamine Injections

Appetite, 1984
6-Hydroxydopamine (6-OHDA) injection into the rat hypothalamus produces profound changes in eating behavior and body weight gain. Willis and Smith have demonstrated an anorexic effect of lateral hypothalamic (LH) 6-OHDA, which they correlate with local catecholamine release from degenerating axons just behind the lesion.
openaire   +2 more sources

Guanosine Protects Glial Cells Against 6-Hydroxydopamine Toxicity

2014
Increasing body of evidence indicates that neuron-neuroglia interaction may play a key role in determining the progression of neurodegenerative diseases including Parkinson's disease (PD), a chronic pathological condition characterized by selective loss of dopaminergic (DA) neurons in the substantia nigra.
GIULIANI, Patricia   +9 more
openaire   +3 more sources

Effect of ceruloplasmin on 6-hydroxydopamine oxidation.

Biochemistry and molecular biology international, 1996
The effects of ceruloplasmin, a blu copper-containing serum glycoprotein, on the oxidation of the neurotoxin 6-hydroxydopamine in several chemical environments were studied. The spontaneous autoxidation of 6-hydroxydopamine proceeded by a free radical chain reaction involving O2-.
MEDDA, ROSARIA   +4 more
openaire   +3 more sources

The Pharmacology of 6-Hydroxydopamine

Annual Review of Pharmacology, 1973
H, Thoenen, J P, Tranzer
openaire   +2 more sources

Pharmacological Actions of 6-Hydroxydopamine

Pharmacological Reviews, 1974
R M, Kostrzewa, D M, Jacobowitz
openaire   +2 more sources

6-Hydroxydopamine and striatal acetylcholine levels

Brain Research, 1974
D S, Grewaal, H C, Fibiger, E G, McGeer
openaire   +2 more sources

6-Hydroxydopamine

2010
Michael H. Bloch   +94 more
openaire   +1 more source

Home - About - Disclaimer - Privacy